Approval · Notice of Compliance 3749 · 2004
TEVETEN PLUS: Notice of Compliance 3749
Issued June 8, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3749
- Date
- June 8, 2004
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Angiotensin ii receptor (at1) antagonist and diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVETEN PLUS | 02253631 | Cancelled Post Market |
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- EPROSARTAN MESYLATE 600 MG per TAB